Paloma Partners Management CO Ab Cellera Biologics Inc. Transaction History

Paloma Partners Management CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$5.72 - $10.65 $352,277 - $655,901	-61,587 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$7.46 - $14.14 $190,826 - $361,701	-25,580 Reduced 29.35%	61,587 $600,000
Q4 2021 Feb 14, 2022	BUY	$12.99 - $17.73 $1.13 Million - $1.55 Million	87,167 New	87,167 $1.25 Million
Q2 2021 Aug 16, 2021	SELL	$20.19 - $34.17 $536,892 - $908,648	-26,592 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$23.29 - $53.2 $619,327 - $1.41 Million	26,592 New	26,592 $903,000

154

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $841M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.